Cargando…

Frailty Testing Pilot Study: Pros and Pitfalls

BACKGROUND: Frailty can be defined as an inflammatory state with a loss of physiologic reserve in multiple systems that manifests as a decreased ability to respond to stressors that ultimately leads to an increased risk of adverse outcomes. The aim of this study was to determine the ease of frailty...

Descripción completa

Detalles Bibliográficos
Autores principales: Adlam, Taylor, Ulrich, Elizabeth, Kent, Missy, Malinzak, Lauren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5755647/
https://www.ncbi.nlm.nih.gov/pubmed/29317953
http://dx.doi.org/10.14740/jocmr3203w
_version_ 1783290611864961024
author Adlam, Taylor
Ulrich, Elizabeth
Kent, Missy
Malinzak, Lauren
author_facet Adlam, Taylor
Ulrich, Elizabeth
Kent, Missy
Malinzak, Lauren
author_sort Adlam, Taylor
collection PubMed
description BACKGROUND: Frailty can be defined as an inflammatory state with a loss of physiologic reserve in multiple systems that manifests as a decreased ability to respond to stressors that ultimately leads to an increased risk of adverse outcomes. The aim of this study was to determine the ease of frailty testing in a pre-kidney transplant clinic and the resources required to do so. A secondary goal was to better understand the utility of frailty testing when evaluating potential kidney transplant recipients. METHODS: Frailty testing was conducted at a pre-kidney transplant clinic in three phases using Fried’s frailty phenotype (shrinking, exhaustion, low physical activity, slowness, and grip strength). RESULTS: A total of 132 frailty tests were completed on 128 patients. Frail patients had significantly higher rates of shrinking (26% vs. 8.5%, P < 0.05), exhaustion (82.6% vs. 27.6%, P < 0.05), low physical activity (78.2% vs. 19.0%, P < 0.05), slow walking (60.8% vs. 15.2%, P < 0.05), and grip strength (73.9% vs. 25.7%, P < 0.05). When comparing the listing of frail and non-frail patients for transplant, a significantly lower proportion of frail patients were listed compared to non-frail patients (30.4% vs. 57.6%, P < 0.05). Frailty testing was most complete when an examiner dedicated to frailty testing performed the testing. CONCLUSIONS: Frailty testing is feasible to complete in a pre-transplant clinic with an appropriate investment in personnel and resources.
format Online
Article
Text
id pubmed-5755647
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elmer Press
record_format MEDLINE/PubMed
spelling pubmed-57556472018-01-09 Frailty Testing Pilot Study: Pros and Pitfalls Adlam, Taylor Ulrich, Elizabeth Kent, Missy Malinzak, Lauren J Clin Med Res Original Article BACKGROUND: Frailty can be defined as an inflammatory state with a loss of physiologic reserve in multiple systems that manifests as a decreased ability to respond to stressors that ultimately leads to an increased risk of adverse outcomes. The aim of this study was to determine the ease of frailty testing in a pre-kidney transplant clinic and the resources required to do so. A secondary goal was to better understand the utility of frailty testing when evaluating potential kidney transplant recipients. METHODS: Frailty testing was conducted at a pre-kidney transplant clinic in three phases using Fried’s frailty phenotype (shrinking, exhaustion, low physical activity, slowness, and grip strength). RESULTS: A total of 132 frailty tests were completed on 128 patients. Frail patients had significantly higher rates of shrinking (26% vs. 8.5%, P < 0.05), exhaustion (82.6% vs. 27.6%, P < 0.05), low physical activity (78.2% vs. 19.0%, P < 0.05), slow walking (60.8% vs. 15.2%, P < 0.05), and grip strength (73.9% vs. 25.7%, P < 0.05). When comparing the listing of frail and non-frail patients for transplant, a significantly lower proportion of frail patients were listed compared to non-frail patients (30.4% vs. 57.6%, P < 0.05). Frailty testing was most complete when an examiner dedicated to frailty testing performed the testing. CONCLUSIONS: Frailty testing is feasible to complete in a pre-transplant clinic with an appropriate investment in personnel and resources. Elmer Press 2018-02 2017-12-30 /pmc/articles/PMC5755647/ /pubmed/29317953 http://dx.doi.org/10.14740/jocmr3203w Text en Copyright 2018, Adlam et al. http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Adlam, Taylor
Ulrich, Elizabeth
Kent, Missy
Malinzak, Lauren
Frailty Testing Pilot Study: Pros and Pitfalls
title Frailty Testing Pilot Study: Pros and Pitfalls
title_full Frailty Testing Pilot Study: Pros and Pitfalls
title_fullStr Frailty Testing Pilot Study: Pros and Pitfalls
title_full_unstemmed Frailty Testing Pilot Study: Pros and Pitfalls
title_short Frailty Testing Pilot Study: Pros and Pitfalls
title_sort frailty testing pilot study: pros and pitfalls
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5755647/
https://www.ncbi.nlm.nih.gov/pubmed/29317953
http://dx.doi.org/10.14740/jocmr3203w
work_keys_str_mv AT adlamtaylor frailtytestingpilotstudyprosandpitfalls
AT ulrichelizabeth frailtytestingpilotstudyprosandpitfalls
AT kentmissy frailtytestingpilotstudyprosandpitfalls
AT malinzaklauren frailtytestingpilotstudyprosandpitfalls